NPI registry status
Active
2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1407477318 MD
Verify on CMS → Anfei Li, MD
Glaucoma Specialist (Ophthalmology) Physician in Bala Cynwyd, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 383 in Glaucoma Specialist (Ophthalmology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 722 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
62%
generic claims · 38% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$216
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Anfei Li, MD filed 2,270 Medicare Part D claims in 2024 as a Glaucoma Specialist (Ophthalmology) Physician in Bala Cynwyd, Pennsylvania, prescribing 62% generic.
- 2K
- Part D claims, 2024
- 62%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥85th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Anfei Li, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1407477318), first enumerated 05/01/2020.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,270 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
3 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$216 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Pennsylvania statewide board action statistics are published annually — these figures describe aggregate state activity, not Anfei Li, MD's individual license status. Verify directly with the state medical board.
Source: PA-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1407477318 · Glaucoma Specialist (Ophthalmology) Physician
NPI-10 · ENUM-RECENT · TAX-TRACE · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1407477318
- ENUM-RECENT 2020
- TAX-TRACE 383
- RX-MID 2,270
- BOOK-THIN 26 in Pennsylvania
- PHOTO-ENUM Brian Nguyen, DO · 2020
Anfei Li, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
2,270 ≥ 85th percentile 85% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Anfei Li, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 3 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Anfei Li, MD?
Quality data not reportedPrimary specialty
Glaucoma Specialist (Ophthalmology) Physician
Medicare Part D claims
2,270 25% vs specialty avg
Specialty distribution in Pennsylvania
How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Glaucoma Specialist (Ophthalmology) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1407477318 |
|---|---|
| Specialty | Glaucoma Specialist (Ophthalmology) Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/01/2020 |
Hospital and facility affiliations
Facilities where Anfei Li, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Anfei Li, MD is affiliated with 3 Medicare-billing facilities across 2 states.
Ophthalmic Partners PC
Bala Cynwyd, PA
Trustees OF Columbia University IN The City OF New York
New York, NY
Wills Eye Ophthalmology Clinic, Inc
Philadelphia, PA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Anfei Li, MD. Source: openpaymentsdata.cms.gov.
Total received
$216
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Anfei Li, MD. To verify Anfei Li, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Anfei Li, MD - brand share 38.0%
Glaucoma Specialist (Ophthalmology) Physician average
38% brand-name claims vs 62% generic, on 2,270 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,270
Total Claims
$405K
Total Drug Cost
722
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,656.867
- Total Day Supply
- 104,105
- Brand vs Generic
- 38% brand / 62% generic
- Brand Drug Cost
- $362K
- Generic Drug Cost
- $42K
Patient Demographics
- Average Patient Age
- 77.1 years
- Avg HCC Risk Score
- 1.36
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 23, 65-74: 259, 75-84: 295, 85+: 145
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Anfei Li, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Latanoprost
Latanoprost
484 claims
- Dorzolamide-Timolol
Dorzolamide-Timolol
230 claims
- Brimonidine Tartrate
Brimonidine Tartrate
218 claims
- Timolol Maleate 147
Timolol Maleate
147 claims
- Prednisolone Acetate 127
Prednisolone Acetate
127 claims
- Restasis 121
Restasis
121 claims
- Dorzolamide Hcl 112
Dorzolamide Hcl
112 claims
- Moxifloxacin 84
Moxifloxacin
84 claims
| Drug | Claims |
|---|---|
| Latanoprost | 484 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 230 |
| Brimonidine Tartrate | 218 |
| Timolol Maleate | 147 |
| Prednisolone Acetate | 127 |
| Restasis Cyclosporine | 121 |
| Dorzolamide Hcl | 112 |
| Moxifloxacin Moxifloxacin Hcl | 84 |
| Rhopressa Netarsudil Mesylate | 83 |
| Combigan Brimonidine Tartrate/Timolol | 62 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Glaucoma Specialist (Ophthalmology) Physician in PA →
All providers in Pennsylvania →
Compare specialties →
Glaucoma Specialist (Ophthalmology) Physician Overview
How Anfei Li, MD fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.
383
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
3,029
Avg Claims per Provider
Anfei Li, MD's 2,270 claims are below the specialty average of 3,029.
Nationwide Glaucoma Specialist (Ophthalmology) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Li, both outside Pennsylvania so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2020)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Li.
One of 26 Glaucoma Specialist (Ophthalmology) Physician providers enrolled in Pennsylvania, 5 are shown here.
Dr. Victoria Addis
M.D.
Philadelphia, PA
Dilru Amarasekera
Philadelphia, PA
Dr. Kaushik Annam
MD
Bethlehem, PA
Dr. Cristan Arena
M.D.
West Chester, PA
Dr. Marguerite Billbrough
MD
Media, PA
Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Anfei Li, MD's specialty? ▼
Anfei Li, MD specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in Bala Cynwyd, Pennsylvania. Credentials: MD.
How much does Anfei Li, MD prescribe under Medicare Part D? ▼
In 2024, Anfei Li, MD wrote 2,270 Medicare Part D claims totaling $405K in drug costs for 722 beneficiaries.
Where is Anfei Li, MD located? ▼
Anfei Li, MD is located at 100 PRESIDENTIAL BLVD STE 200, Bala Cynwyd, PA, 19004. Phone: (484) 434-2700.
What is Anfei Li, MD's NPI number? ▼
Anfei Li, MD's National Provider Identifier (NPI) is 1407477318, issued on 05/01/2020.
Does Anfei Li, MD prescribe more brand-name or generic drugs? ▼
Anfei Li, MD's prescribing is 38% brand-name and 62% generic drugs by claim count, with $362K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US? ▼
There are 383 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 3,029 Medicare Part D claims per year.
What drugs does Anfei Li, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Anfei Li, MD's most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Brimonidine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Anfei Li, MD accept Medicare? ▼
Anfei Li, MD appears in CMS Medicare data with 2,270 Part D claims and 722 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Anfei Li, MD's credentials? ▼
Anfei Li, MD's NPI is 1407477318 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.